Antiviral prophylaxis cannot reduce the risk of hepatitis B reactivation during chemotherapy for non-HCC solid tumor patients with lower HBV DNA titer: A retrospective cohort study | |
Gin, Q.; Zhou, A.; Yang, L.; Zhong, D. | |
2018 | |
会议名称 | ANNALS OF ONCOLOGY |
会议日期 | 2018-10-01 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6349304 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Gin, Q.,Zhou, A.,Yang, L.,et al. Antiviral prophylaxis cannot reduce the risk of hepatitis B reactivation during chemotherapy for non-HCC solid tumor patients with lower HBV DNA titer: A retrospective cohort study[C]. 见:ANNALS OF ONCOLOGY. 2018-10-01. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论